Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States... Show more
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GTBIF's RSI Oscillator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The 10-day moving average for GTBIF crossed bullishly above the 50-day moving average on May 06, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GTBIF advanced for three days, in of 305 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 187 cases where GTBIF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Momentum Indicator moved below the 0 level on May 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GTBIF as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for GTBIF turned negative on May 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .
GTBIF moved below its 50-day moving average on May 08, 2025 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GTBIF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
GTBIF broke above its upper Bollinger Band on April 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.003) is normal, around the industry mean (60.596). P/E Ratio (172.414) is within average values for comparable stocks, (88.278). Projected Growth (PEG Ratio) (0.576) is also within normal values, averaging (2.913). Dividend Yield (0.000) settles around the average of (0.120) among similar stocks. P/S Ratio (1.653) is also within normal values, averaging (19.312).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GTBIF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GTBIF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
Industry PharmaceuticalsOther
A.I.dvisor indicates that over the last year, GTBIF has been closely correlated with CURLF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if GTBIF jumps, then CURLF could also see price increases.
Ticker / NAME | Correlation To GTBIF | 1D Price Change % | ||
---|---|---|---|---|
GTBIF | 100% | +3.07% | ||
CURLF - GTBIF | 82% Closely correlated | +0.12% | ||
TCNNF - GTBIF | 82% Closely correlated | +3.91% | ||
VRNOF - GTBIF | 79% Closely correlated | +3.80% | ||
TSNDF - GTBIF | 77% Closely correlated | +8.48% | ||
CRLBF - GTBIF | 71% Closely correlated | +3.73% | ||
More |